Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 108 | 1 | 102 | −5 |
| Shares | 39.5M | 3.32K | 40.0M | +533.6K (+1.4%) |
| Value | $929.9M | $79.0K | $196.6M | −$733.2M (−78.9%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | – | $612.0K | 0.00% |
| Millennium Management LLC | 81,197 | $398.0K | 0.00% |
| Renaissance Technologies LLC | 68,000 | $333.0K | 0.00% |
| Qube Research & Technologies Ltd | 31,813 | $156.0K | 0.00% |
| Occudo Quantitative Strategies LP | 31,438 | $154.0K | 0.01% |
| Jump Financial, LLC | 29,000 | $142.0K | 0.01% |
| XTX Topco Ltd | 27,799 | $136.0K | 0.06% |
| Cornercap Investment Counsel Inc | 25,941 | $127.0K | 0.02% |
| Stifel Financial Corp | 24,600 | $121.0K | 0.00% |
| Gsa Capital Partners LLP | 22,822 | $112.0K | 0.02% |
| Engineers Gate Manager LP | 21,356 | $105.0K | 0.00% |
| Ameriprise Financial Inc | 20,664 | $101.0K | 0.00% |
| Susquehanna International Group, LLP | 17,687 | $87.0K | 0.00% |
| Healthcare of Ontario Pension Plan Trust Fund | 17,000 | $83.0K | 0.00% |
| Balyasny Asset Management LLC | 15,684 | $77.0K | 0.00% |
| AQR Capital Management LLC | 13,966 | $68.0K | 0.00% |
| Delphia (USA) Inc. | 11,784 | $58.0K | 0.04% |
| Point72 Hong Kong Ltd | 4,495 | $22.0K | 0.00% |
| Group One Trading, L.P. | 91 | $0 | 0.00% |
| Captrust Financial Advisors | 72 | $0 | 0.00% |
Sold out (25)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Polar Capital Holdings Plc | 500,000 | $11.8M |
| Monashee Investment Management LLC | 236,991 | $5.60M |
| Sofinnova Investments, Inc. | 229,509 | $5.43M |
| Paradigm Biocapital Advisors LP | 212,961 | $5.04M |
| Lord, Abbett & Co. LLC | 188,651 | $4.46M |
| Opaleye Management Inc. | 136,000 | $3.22M |
| First Manhattan Co | 116,622 | $2.76M |
| Norges Bank | 87,100 | $2.06M |
| Cinctive Capital Management LP | 66,120 | $1.56M |
| Fred Alger Management, LLC | 48,921 | $1.16M |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 17,797 | $421.0K |
| MetLife Investment Management | 15,001 | $354.8K |
| Blackstone Group Inc. | 9,500 | $225.0K |
| Virtus ETF Advisers LLC | 9,496 | $225.0K |
| ProShare Advisors LLC | 9,351 | $221.0K |
| Belvedere Trading LLC | 15,785 | $201.0K |
| Allspring Global Investments Holdings, LLC | 5,277 | $124.0K |
| Quantbot Technologies LP | 4,600 | $108.0K |
| Caption Management, LLC | 4,187 | $99.0K |
| Metropolitan Life Insurance Co | 1,783 | $42.2K |
| UBS Group AG | 1,469 | $35.0K |
| US Bancorp | 790 | $19.0K |
| Signaturefd, LLC | 254 | $6.00K |
| Quadrant Capital Group LLC | 92 | $2.00K |
| Toronto Dominion Bank | 3 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 3,324 | $79.0K |